The Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Controlled Evaluation (ADVANCE) – the benefits of hyperglycaemia intensive treatment in patients with type 2 diabetes mellitus

Józef Drzewoski

eISSN: 2084-9877
ISSN: 1896-9666

Przegląd Kardiodiabetologiczny/Cardio-Diabetological Review

Current issue Archive About the journal Contact Instructions for authors

3/2008
vol. 3

Send email

Copy url:

abstract:

The Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Controlled Evaluation (ADVANCE) – the benefits of hyperglycaemia intensive treatment in patients with type 2 diabetes mellitus

Józef Drzewoski

Przegląd Kardiodiabetologiczny 2008; 3, 3: 254–259

Online publish date: 2008/10/20

View full text Get citation

The article describes the results of the hypoglycaemic arm of the ADVANCE Trial and compares the obtained data with the results of the ACCORD and VADT studies.

keywords:

The Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Controlled Evaluation (ADVANCE) – the benefits of hyperglycaemia intensive treatment in patients with type 2 diabetes mellitus

Józef Drzewoski

ADVANCE, type 2 diabetes mellitus, intensive treatment, conventional treatment